Related Experiment Videos
[Feline leukemogenic and sarcomatogenic viruses]
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|January 1, 1975
Summary
Feline Leukemia and sarcoma viruses (FeLV, FeSV) are oncogenic RNA viruses. Research into FeLV/FeSV vaccination is underway, exploring antibody correlations with tumor regression in cats.
Area of Science:
- Virology
- Oncology
- Immunology
Context:
- Feline Leukemia Virus (FeLV) and Feline Sarcoma Virus (FeSV) are Oncornaviruses with known oncogenic properties in various species.
- FeLV is prevalent in domestic cats, transmitted horizontally.
- Human susceptibility to FeLV and FeSV remains unestablished.
Purpose:
- To investigate the oncogenic potential of FeLV and FeSV in different species.
- To explore the correlation between humoral antibodies and tumor regression induced by FeSV.
- To guide current investigations into FeLV/FeSV vaccination strategies.
Summary:
- FeLV and FeSV are RNA Oncornaviruses sharing characteristics with other mammalian and avian leukemia/sarcoma viruses.
- While oncogenic in dogs and non-human primates, human susceptibility is unknown.
- Antibody responses against specific membrane antigens are linked to FeSV tumor regression, informing vaccine development.
Impact:
- Provides insights into FeLV/FeSV oncogenesis and interspecies disease transmission.
- Highlights the potential for FeLV/FeSV vaccination development based on immunological responses.
- Contributes to understanding viral oncology and feline disease management.